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ABSTRACT
Background: Since the advent of highly active antiretroviral therapy in the mid-nineties, deaths among persons living with
HIV (PLWH) have declined nationally. Now a controllable condition, HIV has become a chronic disease, highlighting the
importance of tobacco cessation in lowering morbidity and premature mortality. Current smoking is approximately twice as
high among PLWH compared with the general population. PLWH who smoke experience higher rates of cardiovascular
disease, AIDS-defining illnesses, and cancer than PLWH who do not smoke. Loss of life-years associated with smoking
among PLWH is greater than life-years lost from HIV.
Methods: Data on current smoking, derived from the 2009-12 Georgia Medical Monitoring Project (MMP) were analyzed.
Smoking rates were calculated by demographic characteristics, and results were compared to those from the 2011 Georgia
Behavioral Risk Factor Surveillance System (BRFSS), a population-based telephone survey.
Results: The prevalence of current smoking among PLWH was 36.1%, compared with 21.2% among the general population
in Georgia. Smoking prevalence for PLWH generally varied by demographic characteristics according to the same pattern as
for the general population, but prevalence was consistently higher among PLWH.
Conclusions: The prevalence of current smoking among PLWH in Georgia is high. Clinical and public health interventions
must address smoking cessation as part of HIV care to prevent disease, improve quality of life, and reduce mortality. HIVinfected smokers have more barriers to quitting (alcohol, depression, drug dependence, and inaccurate risk perception) and a
lower quit rate than non-HIV-infected smokers. Efficacy studies of behavioral and pharmacological interventions for smoking
cessation specific to PLWH are needed.
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compared to the general population (quit ratios: 32.4% vs.
51.7%, respectively) (Mdodo et al., 2015). Tobacco use is
high among PLWH due to several underlying factors. Both
tobacco use and HIV are associated with lower educational
achievement, lower income level, concurrent drug use, and
mental illness (O’Cleirigh et al., 2015). Tobacco use
presents an increased risk of both AIDS-defining and other
diseases for HIV-infected smokers, compounding the effect
of high rates of smoking in this population (Helleberg et al.,
2013).

INTRODUCTION
Approximately 1.2 million people within the United
States
are
currently
living
with
human
immunodeficiency virus (HIV) infections, and, in Georgia
50,436, people were living with diagnosed HIV as of
December 31, 2012 (The Georgia Department of Public
Health Fact Sheet: HIV Surveillance, Georgia, 2012). Due
to the advancement of antiretroviral therapy, people
living with HIV (PLWH) are living longer. As PLWH age,
they face the same chronic illnesses as the general
population, including cardiovascular disease and chronic
obstructive pulmonary disease (Moscou-Jackson,
Commodore-Mensah, Farley, & DiGiacomo, 2014).

The purpose of this study was to compare the prevalence of
smoking among PLWH in Georgia to that for the general
population in Georgia, using data from the Georgia Medical
Monitoring Project (MMP), a representative sample of
persons in HIV care in Georgia, and data from the Georgia
Behavioral Risk Factor Surveillance System (BRFSS).
Understanding the prevalence and harmful effects of
tobacco use among Georgians living with HIV will inform
tobacco cessation programs specific to Georgia as well as
educate HIV care providers in Georgia.

Smoking prevalence among PLWH is higher than that of the
general population. An estimated 21.2% of adults in the
United States smoke cigarettes (CDC, 2013; Browning,
Wewers, Ferketich, & Diaz, 2013), but a study of a
nationally representative sample of HIV-infected persons in
care found adults with HIV were nearly twice as likely to
smoke compared to adults in the general population (42.4%
and 20.6%, respectively) and were less likely to quit
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smoking prevalence among the general population of
Georgia adults by sociodemographic variables. BRFSS
collects information regarding health risk behaviors, health
conditions, and use of healthcare services. Data are
collected in all 50 states, and the surveys are completed via
telephone interviews. Beginning in 2011, BRFSS collected
data from both landline telephones, using a disproportionate
stratified sampling method, and cellular telephones, using a
random, probability sampling method. BRFSS data, like
MMP data, are weighted to produce nationally
representative samples as well as representative samples for
each state (“CDC - BRFSS,”). Analyses were conducted
using SAS 9.2.

METHODS
The Georgia MMP data from 2009-2012 were analyzed to
estimate smoking prevalence by sociodemographic variables
among smokers. MMP is a surveillance system that collects
data about behavioral and clinical aspects of PLWH who are
currently receiving medical care (“Georgia Medical
Monitoring Project (MMP) | Georgia Department of Public
Health”). MMP utilizes a three-stage, probability sampling
method, and Georgia is one of 26 states and cities across the
United States that participates. Within project areas,
facilities and patients within those facilities are randomly
selected. Interviews are conducted either face-to-face or via
telephone to obtain behavioral information, and medical
records are used to obtain clinical information. To be
eligible to participate, individuals are required to be HIVinfected, 18 years of age or older at the time of the
interview, and actively receiving medical care for HIV. Data
from the Georgia MMP are weighted to produce a
representative sample of all adult Georgians receiving
medical care for HIV (McNaghten et al., 2007; Blair et al.,
2011; Frankel et al., 2012). Because results varied
minimally during 2009-2012, data from the four survey
years were pooled to achieve a larger sample size.
The Georgia Behavioral Risk Factor Surveillance System
(BRFSS) data from 2011 were analyzed to estimate

RESULTS
Smoking prevalence among PLWH in Georgia was almost
twice as high as smoking prevalence among the general
population (36.1% vs. 21.2%). For PLWH, current smoking
was more common among females than males, whites than
blacks, persons with a high school education or less, and
persons 25 years and older. With the exception of
differences by sex, similar patterns were seen in the general
population. Within each subgroup, current smoking was
higher among PLWH (Table 1).

Table 1. Prevalence of Current Smoking by Demographics, PLWH (MMP 2009-2012)
and all Adults (BRFSS 2011) in Georgia
PLWH

All Adults

Georgia MMP 2009-2012

Georgia BRFSS 2011

Smoker %

Unweighted N*

(Weighted)

Unweighted N

Smoker %
(Weighted)

Overall

607

36

1,612

21

Sex
Female

172

39

942

18

Male

429

35

670

23

White

138

41

1,159

24

Black

407

34

331

17

Hispanic

Race/Ethnicity

26

-*

46

13

Education
<High school

95

55

292

36

H.S. graduate

172

43

562

24

>High school

340

27

752

15

29

-*

84

25

25-44

261

40

425

24

45-64

290

36

780

22

65+

26

-*

288

13

Income
Less than $20K

137

40

492

33

$20K or more

103

24

919

17

Age in years
18-24

*unreliable estimate
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of addiction behavior (Rosenberg, 2014; Kandel & Kandel,
2014). Priming mice with nicotine also enhances the effect
of cocaine. This priming effect has implications for harm
reduction approaches, such as the use of e-cigarettes (Levine
et al., 2005). Since e-cigarettes are nicotine-delivery
devices, they do not provide an optimal strategy for harm
reduction for populations with high substance abuse
prevalence due to the effect of nicotine on enhancement of
the effects of other drugs. By such enhancement, ecigarettes pose the same risks as traditional cigarettes and
present additional barriers to cessation of tobacco and
substance use (Kandel & Kandel, 2014).

DISCUSSION
In the United States, tobacco use is the leading cause of
preventable illness and death, and after viral suppression,
tobacco cessation remains the number one health priority for
PLWH who smoke. In Georgia, rates of current smoking are
almost twice as high among PLWH than among the general
population. The findings are consistent with those of other
studies on smoking prevalence among PLWH.
PLWH who smoke have a substantially increased risk of
cardiovascular disease; AIDS-defining conditions, including
candidiasis, bacterial pneumonia, cervical cancer, and anal
cancer; lung cancer; and liver cancer (Helleberg et al., 2013;
Kwong & Bouchard-Miller, 2010; Lifson 2010). Smoking
causes a systemic inflammation and decreases immune
function, which contributes to the increased risk of diseases
and certain types of cancers (Helleberg et al., 2013) .
Compared to smokers in the general population, HIVinfected smokers are more susceptible to developing chronic
obstructive pulmonary disorder (Crothers et al., 2006).
Premature mortality is also substantially increased in PLWH
who smoke compared to those who do not smoke (Figure 1)
(Helleberg et al., 2013). Life expectancy for a 35-year-old
HIV patient who smokes is 62.6 years, compared with 78.4
years for a non-smoking patient with HIV. Both all-cause
and AIDS mortality are higher among PLWH who smoke,
including a nearly five-fold increased risk of death caused
by cardiovascular disease and cancer compared to HIVinfected non-smokers (Helleberg et al, 2013). The
attributable risk of death associated with smoking is 61.5%
among PLWH compared to 34.2% among HIV-negative
controls.

In the general population, only 20.9% of smokers receive
tobacco cessation counseling, and only 7.6% receive
tobacco cessation medication (Jamal et al., 2012). Some
studies have demonstrated that providers of healthcare to
PLWH are more likely to discuss tobacco cessation
strategies with their patients than primary care providers;
however, only half of all such providers report screening
and counseling for tobacco use (Benard et al.,
2007;Tesoriero, Gieryic, Carrascal, & Lavigne, 2010).
Shuter et al. examined smoking behaviors among PLWH
and found and 83% of participants reported their primary
care provider initiated discussions regarding smoking.
However, only 32.8% were referred to a quit line, and only
5.3% were referred to a smoking cessation program (Shuter,
Bernstein, & Moadel, 2012). Reasons for lack of adequate
counseling by those providing care to PLWH were that
tobacco cessation counseling involved time limitations
and/or that they felt unqualified to counsel (Shuter et al.,
2012).
Limitations
PLWH who are not receiving care or not receiving
consistent care were not included in this sample. Individuals
receiving care may be more health conscious and less likely
to smoke than individuals who are not receiving care;
therefore, smoking prevalence among Georgians living with
HIV may be underestimated. The response rates for the
Georgia MMP were 27.39% for 2009, 17.58% for 2010,
23.23% for 2011, and 34.71% for 2012. The adjusted
response rate for Georgia BRFSS was 49.92% for 2011.
Lower response rates could lead to nonresponse bias and
affect the generalizability of results.

Cigarette smoking is associated with lower adherence to
antiretroviral therapy (ART) (Shuter & Bernstein, 2008),
and smoking is also associated with a greater risk of
virologic failure (Feldman et al., 2006). Even after
controlling for adherence, cigarette smoking was associated
with a decrease in the efficacy of ART, suggesting that an
underlying biological mechanism exists between smoking
and ART (O’Cleirigh et al., 2015).
Due to the high prevalence of smoking among PLWH and
the increased risk of disease and premature mortality among
HIV-infected smokers, tobacco cessation should be a goal
for HIV care providers. However, there are many barriers to
quitting. Inaccurate risk perceptions, depression and mental
illness, and concurrent alcohol and drug use all negatively
impact tobacco cessation efforts (O’Cleirigh et al., 2015).
Cessation counseling programs for patients who are
codependent on other substances (e.g., alcohol and
marijuana) are more successful when both substance abuse
cessation and tobacco cessation are included than when
either cessation program is implemented alone (Helleberg
et al., 2013).

Implications for Public Health
Findings of high smoking prevalence among PLWH
combined with the increased risk of diseases and mortality
for PLWH smokers highlight the importance of tobacco
cessation among this population. These results should
inform tobacco cessation programs tailored to people living
with HIV in Georgia. A recent review assessed tobacco
cessation programs among HIV-positive persons (MoscouJackson et al., 2014). Interventions that incorporated cell
phone cessation strategies were the most successful at
increasing smoking cessation rates (Vidrine, Arduino,
Lazev, & Gritz, 2006; Vidrine, Marks, Arduino, & Gritz,
2012). The review concluded that the most successful
interventions were adjusted to address specific needs of
disorders were more successful at achieving tobacco
cessation than interventions that did not address these

Recent molecular biology research demonstrates that
nicotine causes structural changes in ΔFosB receptors in the
mouse brain striatum, which is a factor in the development
PLWH (Moscou-Jackson et al., 2014). Also, interventions
that addressed co-occurring substance abuse and psychiatric
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